True Vision MN LLC Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

True Vision MN LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,536 shares of the company's stock, valued at approximately $531,000.

Other large investors also recently added to or reduced their stakes in the company. Atwood & Palmer Inc. acquired a new position in HCA Healthcare during the 1st quarter valued at $28,000. Bartlett & CO. Wealth Management LLC raised its stake in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after buying an additional 80 shares in the last quarter. Tidemark LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $36,000. ORG Partners LLC raised its stake in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after buying an additional 86 shares in the last quarter. Finally, Legacy Investment Solutions LLC grew its holdings in shares of HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after purchasing an additional 95 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

HCA has been the topic of a number of research analyst reports. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Barclays set a $416.00 price objective on shares of HCA Healthcare and gave the stock an "overweight" rating in a report on Monday, June 2nd. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Royal Bank Of Canada reissued an "outperform" rating and set a $404.00 price objective (up previously from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Seven analysts have rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and a consensus price target of $395.71.

Insider Activity

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.30% of the stock is owned by insiders.

HCA Healthcare Price Performance

NYSE HCA opened at $378.27 on Thursday. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a market capitalization of $91.00 billion, a PE ratio of 16.82, a price-to-earnings-growth ratio of 1.30 and a beta of 1.47. The firm's 50 day moving average is $373.87 and its 200-day moving average is $340.71.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same period last year, the business earned $5.36 earnings per share. The firm's revenue was up 5.7% on a year-over-year basis. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.76%. HCA Healthcare's payout ratio is currently 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.